De novo production of benzyl glucosinolate in Escherichia coli

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

De novo production of benzyl glucosinolate in Escherichia coli. / Petersen, Annette; Crocoll, Christoph; Halkier, Barbara Ann.

I: Metabolic Engineering, Bind 54, 01.07.2019, s. 24-34.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Petersen, A, Crocoll, C & Halkier, BA 2019, 'De novo production of benzyl glucosinolate in Escherichia coli', Metabolic Engineering, bind 54, s. 24-34. https://doi.org/10.1016/j.ymben.2019.02.004

APA

Petersen, A., Crocoll, C., & Halkier, B. A. (2019). De novo production of benzyl glucosinolate in Escherichia coli. Metabolic Engineering, 54, 24-34. https://doi.org/10.1016/j.ymben.2019.02.004

Vancouver

Petersen A, Crocoll C, Halkier BA. De novo production of benzyl glucosinolate in Escherichia coli. Metabolic Engineering. 2019 jul. 1;54:24-34. https://doi.org/10.1016/j.ymben.2019.02.004

Author

Petersen, Annette ; Crocoll, Christoph ; Halkier, Barbara Ann. / De novo production of benzyl glucosinolate in Escherichia coli. I: Metabolic Engineering. 2019 ; Bind 54. s. 24-34.

Bibtex

@article{503d7ef749a94c859aa684db353c5940,
title = "De novo production of benzyl glucosinolate in Escherichia coli",
abstract = "Microbial production of plant specialised metabolites is challenging as the biosynthetic pathways are often complex and can contain enzymes, which function is not supported in traditional production hosts. Glucosinolates are specialised metabolites of strong commercial interest due to their health-promoting effects. In this work, we engineered the production of benzyl glucosinolate in Escherichia coli. We systematically optimised the production levels by first screening different expression strains and by modification of growth conditions and media compositions. This resulted in production from undetectable to approximately 4.1 μM benzyl glucosinolate, but also approximately 3.7 μM of desulfo-benzyl glucosinolate, the final intermediate of this pathway. Additional optimisation of pathway flux through entry point cytochrome P450 enzymes and PAPS-dependent sulfotransferase increased the production additionally 5-fold to 20.3 μM (equivalent to 8.3 mg/L) benzyl glucosinolate.",
keywords = "Escherichia coli, Glucosinolates, Metabolic engineering, Targeted proteomics",
author = "Annette Petersen and Christoph Crocoll and Halkier, {Barbara Ann}",
year = "2019",
month = jul,
day = "1",
doi = "10.1016/j.ymben.2019.02.004",
language = "English",
volume = "54",
pages = "24--34",
journal = "Metabolic Engineering",
issn = "1096-7176",
publisher = "Academic Press",

}

RIS

TY - JOUR

T1 - De novo production of benzyl glucosinolate in Escherichia coli

AU - Petersen, Annette

AU - Crocoll, Christoph

AU - Halkier, Barbara Ann

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Microbial production of plant specialised metabolites is challenging as the biosynthetic pathways are often complex and can contain enzymes, which function is not supported in traditional production hosts. Glucosinolates are specialised metabolites of strong commercial interest due to their health-promoting effects. In this work, we engineered the production of benzyl glucosinolate in Escherichia coli. We systematically optimised the production levels by first screening different expression strains and by modification of growth conditions and media compositions. This resulted in production from undetectable to approximately 4.1 μM benzyl glucosinolate, but also approximately 3.7 μM of desulfo-benzyl glucosinolate, the final intermediate of this pathway. Additional optimisation of pathway flux through entry point cytochrome P450 enzymes and PAPS-dependent sulfotransferase increased the production additionally 5-fold to 20.3 μM (equivalent to 8.3 mg/L) benzyl glucosinolate.

AB - Microbial production of plant specialised metabolites is challenging as the biosynthetic pathways are often complex and can contain enzymes, which function is not supported in traditional production hosts. Glucosinolates are specialised metabolites of strong commercial interest due to their health-promoting effects. In this work, we engineered the production of benzyl glucosinolate in Escherichia coli. We systematically optimised the production levels by first screening different expression strains and by modification of growth conditions and media compositions. This resulted in production from undetectable to approximately 4.1 μM benzyl glucosinolate, but also approximately 3.7 μM of desulfo-benzyl glucosinolate, the final intermediate of this pathway. Additional optimisation of pathway flux through entry point cytochrome P450 enzymes and PAPS-dependent sulfotransferase increased the production additionally 5-fold to 20.3 μM (equivalent to 8.3 mg/L) benzyl glucosinolate.

KW - Escherichia coli

KW - Glucosinolates

KW - Metabolic engineering

KW - Targeted proteomics

UR - http://www.scopus.com/inward/record.url?scp=85063026606&partnerID=8YFLogxK

U2 - 10.1016/j.ymben.2019.02.004

DO - 10.1016/j.ymben.2019.02.004

M3 - Journal article

C2 - 30831267

AN - SCOPUS:85063026606

VL - 54

SP - 24

EP - 34

JO - Metabolic Engineering

JF - Metabolic Engineering

SN - 1096-7176

ER -

ID: 223678215